載入...
Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients
Safety concerns with erythropoietin analogues and intravenous (IV) iron for treatment of anemia in CKD necessitate development of safer therapies. Roxadustat (FG-4592) is an orally bioavailable hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor that promotes coordinated erythropoiesis throu...
Na minha lista:
| 發表在: | J Am Soc Nephrol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Nephrology
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4814189/ https://ncbi.nlm.nih.gov/pubmed/26494833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2015030241 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|